Underdosing of antirheumatics, not elsewhere classified Save
ICD-10 code: T39.4X6
Chapter: Injury, poisoning and certain other consequences of external causes
Underdosing of antirheumatics, not elsewhere classified: What you need to know
Antirheumatic drugs are used to treat rheumatoid arthritis and other autoimmune diseases, where the immune system attacks the body's own tissues. These drugs work by suppressing the immune system, reducing inflammation and pain. However, underdosing of antirheumatics, not elsewhere classified, can lead to ineffective treatment, disease progression, and complications.
Underdosing of antirheumatics, not elsewhere classified, refers to the use of a lower dose than recommended by the healthcare provider. This may occur due to various reasons such as poor adherence, fear of side effects, financial constraints, or lack of awareness about the importance of the prescribed dose.
Patients who underdose antirheumatics may experience worsening of symptoms, joint damage, disability, and decreased quality of life. In addition, untreated inflammation can lead to other organ damage such as the lungs, kidneys, and heart.
It is essential to follow the prescribed dosage of antirheumatics to achieve optimal therapeutic outcomes. The healthcare provider may adjust the dose based on the patient's response, disease activity, and potential side effects. Therefore, it is crucial to communicate any concerns or issues related to the medication with the healthcare provider.
Here are some tips to avoid underdosing of antirheumatics:
- Take the medication as prescribed by the healthcare provider.
- Do not adjust the dosage without consulting the healthcare provider.
- Inform the healthcare provider about any side effects or concerns related to the medication.
- Follow up with the healthcare provider regularly to monitor disease activity and adjust the medication if necessary.
- Discuss any financial concerns related to the medication with the healthcare provider, as there may be assistance programs available.
In conclusion, underdosing of antirheumatics, not elsewhere classified, can have significant consequences on the patient's health and quality of life. It is essential to follow the prescribed dose and communicate any concerns with the healthcare provider to achieve optimal therapeutic outcomes.